What is Adderall (amphetamine and dextroamphetamine) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall Uses and Indications

Adderall (amphetamine and dextroamphetamine) is primarily used for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy. 1, 2

Primary Indications

ADHD Treatment

  • Adderall is a Schedule II controlled substance that effectively treats ADHD symptoms by:
    • Improving attention and focus
    • Reducing hyperactivity and impulsivity
    • Enhancing executive functioning
    • Improving symptom control with an effect size of approximately 1.0 1

Narcolepsy Treatment

  • Amphetamine compounds like Adderall are recommended for treating narcolepsy in adults 3
  • Benefits for narcolepsy patients include:
    • Reduction in excessive daytime sleepiness
    • Improvement in disease severity
    • Potential reduction in cataplexy symptoms

Mechanism of Action

Adderall works primarily by:

  • Acting as a substrate for monoamine transporters, especially the dopamine transporter (DAT) 4
  • Stimulating the release of norepinephrine affecting both α- and β-adrenergic receptor sites 2
  • Increasing extracellular concentrations of dopamine, norepinephrine, and serotonin 4
  • α-Adrenergic stimulation causes vasoconstriction
  • β-Adrenergic stimulation increases heart rate, stroke volume, and skeletal muscle blood flow 2

Dosing Considerations

  • For ADHD treatment:

    • Starting dose: 5-10 mg daily
    • Maximum daily dose: up to 50 mg daily 1
    • Typically administered in two daily doses 5
    • Average effective dose in adults: approximately 54 mg daily (divided doses) 5
  • For narcolepsy:

    • Dosing should be carefully titrated based on clinical response
    • The American Academy of Sleep Medicine provides a conditional recommendation for dextroamphetamine in narcolepsy 3

Efficacy Evidence

  • In adults with ADHD:

    • 70% of patients show significant improvement (reduction in ADHD rating scale of ≥30%) compared to 7% with placebo 5
    • 42% decrease in ADHD Rating Scale scores with Adderall treatment 5
    • Low doses (mean 10.77 mg/day) may be effective in some adults 6
  • In children with ADHD:

    • Shows robust efficacy versus placebo on behavioral ratings, locomotor activity, and academic measures 7
    • Effects can last up to 12 hours after single doses for some measures 7

Important Warnings and Precautions

  • Black box warning: High potential for abuse and dependence 3
  • Prolonged administration may lead to dependence 3
  • May cause fetal harm based on animal data (human data insufficient to determine risk) 3
  • Common adverse effects include:
    • Headache, anxiety, insomnia
    • Decreased appetite, GI upset
    • Increased heart rate and blood pressure
    • Tremors, agitation 6, 2, 4
  • Caution in patients with anxiety disorders as it may precipitate anxiety symptoms 6
  • Careful monitoring required for cardiovascular effects 2

Monitoring Recommendations

  • Regular follow-up every 3-4 weeks during dose titration
  • Once stabilized, follow-up every 3-6 months
  • Monitor appetite, weight, sleep disturbances, mood changes, and growth parameters 1
  • Electronic prescribing systems for Adderall must meet DEA requirements for authentication, security, and record-keeping 1

Adderall is an effective medication for both ADHD and narcolepsy when properly prescribed and monitored, but requires careful consideration of its potential for abuse and side effects.

References

Guideline

Managing Hyperactivity in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

Journal of the American Academy of Child and Adolescent Psychiatry, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.